Literature DB >> 15761473

The human T-cell leukemia virus type 1 p13II protein: effects on mitochondrial function and cell growth.

D M D'Agostino1, M Silic-Benussi, H Hiraragi, M D Lairmore, V Ciminale.   

Abstract

p13(II) of human T-cell leukemia virus type 1 (HTLV-1) is an 87-amino-acid protein that is targeted to the inner mitochondrial membrane. p13(II) alters mitochondrial membrane permeability, producing a rapid, membrane potential-dependent influx of K(+). These changes result in increased mitochondrial matrix volume and fragmentation and may lead to depolarization and alterations in mitochondrial Ca(2+) uptake/retention capacity. At the cellular level, p13(II) has been found to interfere with cell proliferation and transformation and to promote apoptosis induced by ceramide and Fas ligand. Assays carried out in T cells (the major targets of HTLV-1 infection in vivo) demonstrate that p13(II)-mediated sensitization to Fas ligand-induced apoptosis can be blocked by an inhibitor of Ras farnesylation, thus implicating Ras signaling as a downstream target of p13(II) function.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15761473      PMCID: PMC3057663          DOI: 10.1038/sj.cdd.4401576

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  82 in total

Review 1.  The contribution of mitochondria to common disorders.

Authors:  Gregory M Enns
Journal:  Mol Genet Metab       Date:  2003 Sep-Oct       Impact factor: 4.797

Review 2.  Mitochondrion-targeted apoptosis regulators of viral origin.

Authors:  Patricia Boya; Thomas Roumier; Karine Andreau; Rosa Ana Gonzalez-Polo; Naoufal Zamzami; Maria Castedo; Guido Kroemer
Journal:  Biochem Biophys Res Commun       Date:  2003-05-09       Impact factor: 3.575

Review 3.  Ras proteins: different signals from different locations.

Authors:  John F Hancock
Journal:  Nat Rev Mol Cell Biol       Date:  2003-05       Impact factor: 94.444

Review 4.  Cellular transformation by the HTLV-I Tax protein, a jack-of-all-trades.

Authors:  Michael L Gatza; Julie C Watt; Susan J Marriott
Journal:  Oncogene       Date:  2003-08-11       Impact factor: 9.867

Review 5.  Viroporins.

Authors:  Maria Eugenia Gonzalez; Luis Carrasco
Journal:  FEBS Lett       Date:  2003-09-18       Impact factor: 4.124

6.  The hepatitis C virus p7 protein forms an ion channel that is inhibited by long-alkyl-chain iminosugar derivatives.

Authors:  Davor Pavlović; David C A Neville; Olivier Argaud; Baruch Blumberg; Raymond A Dwek; Wolfgang B Fischer; Nicole Zitzmann
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-28       Impact factor: 11.205

Review 7.  Human T-cell leukemia virus type I and adult T-cell leukemia.

Authors:  Masao Matsuoka
Journal:  Oncogene       Date:  2003-08-11       Impact factor: 9.867

8.  Downregulation of Bcl-xL and activation of caspases during retinoic acid-induced apoptosis in an adult T-cell leukemia cell line.

Authors:  Satoshi Fujimura; Junji Suzumiya; Yasuaki Yamada; Masahide Kuroki; Junko Ono
Journal:  Hematol J       Date:  2003

Review 9.  Seizing of T cells by human T-cell leukemia/lymphoma virus type 1.

Authors:  Genoveffa Franchini; Christophe Nicot; Julie M Johnson
Journal:  Adv Cancer Res       Date:  2003       Impact factor: 6.242

10.  Caspase-dependent alterations of Ca2+ signaling in the induction of apoptosis by hepatitis B virus X protein.

Authors:  Mounia Chami; Davide Ferrari; Pierluigi Nicotera; Patrizia Paterlini-Bréchot; Rosario Rizzuto
Journal:  J Biol Chem       Date:  2003-06-10       Impact factor: 5.157

View more
  21 in total

1.  Enhancement of LFA-1-mediated T cell adhesion by human T lymphotropic virus type 1 p12I1.

Authors:  Seung-Jae Kim; Amrithraj M Nair; Soledad Fernandez; Lawrence Mathes; Michael D Lairmore
Journal:  J Immunol       Date:  2006-05-01       Impact factor: 5.422

2.  Suppression of HTLV-1 replication by Tax-mediated rerouting of the p13 viral protein to nuclear speckles.

Authors:  Vibeke Andresen; Cynthia A Pise-Masison; Uma Sinha-Datta; Marcia Bellon; Valerio Valeri; Robyn Washington Parks; Valentina Cecchinato; Risaku Fukumoto; Christophe Nicot; Genoveffa Franchini
Journal:  Blood       Date:  2011-06-15       Impact factor: 22.113

3.  High-yield production in E. coli and characterization of full-length functional p13II protein from human T-cell leukemia virus type 1.

Authors:  Elka R Georgieva; Peter P Borbat; Christina Fanouraki; Jack H Freed
Journal:  Protein Expr Purif       Date:  2020-04-30       Impact factor: 1.650

4.  HTLV-I p30: a versatile protein modulating virus replication and pathogenesis.

Authors:  Xue Tao Bai; Hicham Hachem Baydoun; Christophe Nicot
Journal:  Mol Aspects Med       Date:  2010-06-04

Review 5.  Viral product trafficking to mitochondria, mechanisms and roles in pathogenesis.

Authors:  Chad D Williamson; Roberta L DeBiasi; Anamaris M Colberg-Poley
Journal:  Infect Disord Drug Targets       Date:  2012-02

6.  Human T-lymphotropic virus type 1 mitochondrion-localizing protein p13(II) is required for viral infectivity in vivo.

Authors:  Hajime Hiraragi; Seung-Jae Kim; Andrew J Phipps; Micol Silic-Benussi; Vincenzo Ciminale; Lee Ratner; Patrick L Green; Michael D Lairmore
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

Review 7.  HTLV-1 Yin and Yang: Rex and p30 master regulators of viral mRNA trafficking.

Authors:  Hicham H Baydoun; Marcia Bellon; Christophe Nicot
Journal:  AIDS Rev       Date:  2008 Oct-Dec       Impact factor: 2.500

Review 8.  HTLV-1 and apoptosis: role in cellular transformation and recent advances in therapeutic approaches.

Authors:  John M Taylor; Christophe Nicot
Journal:  Apoptosis       Date:  2008-06       Impact factor: 4.677

Review 9.  The interaction between mitochondria and oncoviruses.

Authors:  Shujie Song; Shasha Gong; Pragya Singh; Jianxin Lyu; Yidong Bai
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-09-28       Impact factor: 5.187

10.  View and review on viral oncology research.

Authors:  Valeria Bergonzini; Cristiano Salata; Arianna Calistri; Cristina Parolin; Giorgio Palù
Journal:  Infect Agent Cancer       Date:  2010-05-24       Impact factor: 2.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.